1163707-72-9Relevant articles and documents
THYROID HORMONE RECEPTOR BETA AGONIST COMPOUNDS
-
Paragraph 0275, (2021/03/05)
Provided herein are compounds, preferably thyroid hormone receptor beta (THR beta) agonist compounds, compositions thereof, and methods of their preparation, and methods of agonizing THR beta and methods for treating disorders mediated by THR beta.
ORGANIC COMPOUNDS
-
Page/Page column 67, (2010/04/06)
The present invention relates to a compound of formula (I) (I) or a salt thereof, wherein the substituents are as defined in the description, to compositions and use of the compounds in the treatment of diseases ameloriated by inhibition of phosphatidylinositol 3-kinase.